News | Imaging Software Development | July 09, 2021

FDA Clears DL Precise One-click Segmentation and Measurement Tool

The software tool delivers consistent precision in all medical imaging modalities

The FDA has granted 510(k) clearance for DeepLook, Inc.’s DL Precise, a one-click software tool to automate segmentation and measurement of suspicious objects across all medical imaging modalities, delivering critical improvements in workflow and reporting precision.

At left, one-click segmentation and measurement rendered by DL Precise. At right, DL Precise uses vivid color to illustrate segmentation.

July 9, 2021 — The FDA has granted 510(k) clearance for DeepLook, Inc.’s DL Precise, a one-click software tool to automate segmentation and measurement of suspicious objects across all medical imaging modalities, delivering critical improvements in workflow and reporting precision.

Leveraging deterministic algorithms rather than artificial intelligence (AI), DL Precise ensures consistent, reliable results. It instantly renders segmentation by contouring an object’s margins and then measures long and short dimension axes, area and estimated volume. DL Precise’s single-click activation eliminates the complex manual setup that characterizes even semi-automatic segmentation tools today and adds important data to AI region-of-interest findings.  Users, however, retain full control and can modify any automated measurement as desired.

DL Precise is the first of a series of medical imaging products under development by DeepLook Inc., a Connecticut-based software firm founded by a team with a 20-year track record of success with similar patented image analysis technologies in other industries.  Future products will leverage the radiomic data derived from DL Precise’s patented shape-recognition technology that enable automated measurement.

 While imaging technology has advanced profoundly, radiologists still routinely use mouse-driven calipers to estimate the size of suspicious objects – and variability continues to undermine the results.  Moreover, manual measurement is tedious and time-consuming, requiring multiple mouse clicks and drags, hundreds of times each day. Consistent, accurate measurement is essential to assess growth or reduction of suspicious objects over time, a recurring need in both clinical and research settings.

DL Precise’s entry into the emerging marketplace for a consistent measurement tool with its deterministic algorithm helps ensure reliable performance for today’s workflow demands. The company’s future decision-support and diagnostic products will leverage this core technology to offer key radiomic metrics and enhance AI/machine learning applications. At the same time, DeepLook’s vivid color enhancement helps radiologists visually assess the software’s quantification.

While other measurement products are trained on particular imaging modalities, organs or types of nodules, DeepLook’s patented technology applies to any medical image – a universal utility for mammography, ultrasound, CT and MRI.  DL Precise’s automated data can feed directly into structured reports, allowing for easy comparisons even across acquisition modalities – for instance, comparing mammograms to supplemental ultrasound images. 

DL Precise is an affordable plug-in utility that works on any DICOM image and in all 510(k)-cleared viewers.  Integration with PACS partners is simple, adapted to each viewer interface. End users can master the mechanics in minutes. DL Precise has successfully completed its first integration with the mammography workstation of Three Palm Software, a respected industry innovator.

For more information: www.deeplookmedical.com/dl-precise

Related Content

Right mediolateral oblique (MLO) mammograms for different women with the same breast thickness but varying breast density.

Right mediolateral oblique (MLO) mammograms for different women with the same breast thickness but varying breast density.

News | Breast Imaging | July 30, 2021
July 30, 2021 — Volpara Health, a global health technology software leader providing an integrated breast care platfo
According to ARRS’ American Journal of Roentgenology (AJR), the resources required to warm iohexol 350 to body temperature before injection for computed tomography (CT) may not be warranted, given the lack of observed practical benefit.

Values represent number of patients, with percentage in parentheses and 95% CI in brackets (not reported for levels of severity of allergic/allergic-like reactions). 95% CIs were calculated using the Clopper-Pearson exact formula. For events with zero frequency, one-sided 97.5% CIs are provided.

News | Contrast Media | July 30, 2021
Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has signed an agreement with Invitae Corporation, a leader in medical genetics, to bring Invitae's genetic testing services to Volpara's customers in the United States. 
News | Breast Imaging | July 29, 2021
July 29, 2021 — Volpara Health, a global health technology software leader providing an...
Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery.

Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery. Read the original article in Plos One.

Feature | Ultrasound Imaging | July 28, 2021
Outside of medicine, computer-generated virtual twins of real machines like cars or airplanes have been used in engin
If you plan to attend HIMSS21 Aug. 9-13 in Las Vegas, be sure to note that due to health and safety updates, masks will now be required for attendees and exhibitors.

Getty Images

News | HIMSS | July 28, 2021
July 28, 2021 —If you plan to attend HIMSS21 Aug.
Researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London have automated brain MRI image labeling, needed to teach machine learning image recognition models, by deriving important labels from radiology reports and accurately assigning them to the corresponding MRI examinations

Getty Images

News | Magnetic Resonance Imaging (MRI) | July 28, 2021
July 28, 2021 — Researchers from the School of Biomedical Engineering & Imaging Sciences at...
A new Harvey L. Neiman Health Policy Institute study found that patients paid 12% of the costs of secondary imaging interpretation out-of-pocket. Such secondary interpretations are increasingly performed for complex patients, but patients’ liabilities and paid out-of-pocket costs were not previously known.

Getty Images

News | Radiology Imaging | July 28, 2021
July 28, 2021 — A new Harvey L.